Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

How useful is autoantibody screening in adult-onset diabetes?

Nature Clinical Practice Endocrinology & Metabolism volume 2, pages 490–491 (2006)Cite this article

boxed-textGenovese S et al. (2006) Clinical phenotype and β-cell autoimmunity in Italian patients with adult-onset diabetes. Eur J Endocrinol 154: 441–447

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Turner R et al. (1997) UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 350: 1288–1293

    Article  CAS  Google Scholar 

  2. Törn C et al. (2000) Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as type 1 diabetes on clinical grounds. Diabetes Metab Res Rev 16: 442–447

    Article  Google Scholar 

  3. Monge L et al. (2004) A clinically orientated approach increases the efficiency of screening for latent autoimmune diabetes in adults (LADA) in a large clinic-based cohort of patients with diabetes onset over 50 years. Diabet Med 21: 456–459

    Article  CAS  Google Scholar 

  4. Juneja R et al. (2001) Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetes. Metabolism 50: 1008–1013

    Article  CAS  Google Scholar 

  5. Borg H et al. (2002) A 12-year prospective study of the relationship between islet antibodies and β-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes 51: 1754–1762

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice. LK Gilliam and JP Palmer are supported in part by grants from the medical Research Service of the Department of Veteran Affairs, GlaxoSmithKline, and NIH DK053004, DK17047 and RR00037.

Author information

Authors and Affiliations

  1. Acting Instructor of Medicine Endocrinology Research Center, University of Washington, Seattle, WA, USA

    Lisa K Gilliam

  2. Professor of Medicine and Director of the Diabetes Endocrinology Research Center, University of Washington, Seattle, WA, USA

    Jerry P Palmer

Authors
  1. Lisa K Gilliam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jerry P Palmer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lisa K Gilliam.

Ethics declarations

Competing interests

Research supported by a grant from GlaxoSmithKline.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gilliam, L., Palmer, J. How useful is autoantibody screening in adult-onset diabetes?. Nat Rev Endocrinol 2, 490–491 (2006). https://doi.org/10.1038/ncpendmet0268

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0268

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing